Home › Cardiovascular Disease › North Carolina › Winston-Salem
Cardiovascular Disease clinical trials in Winston-Salem, NC
14 studies for Cardiovascular Disease are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Novant Health Forsyth Medical Center, Winston-Salem
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Recruiting
- Wake Forest University Health Sciences, Winston-Salem
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Wake Forest University Health Sciences-Winston-Salem-61707, Winston-Salem
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Recruiting
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Winston-Salem
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
- Wake Forest University Baptist Medical Center, Winston-Salem
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Wake Forest Baptist Hospital-Cardiology, Winston-Salem
- Wake Forest Hospital - Geriatrics, Winston-Salem
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
RecruitingEarly phase 1Healthy volunteers welcome
- Wake Forest University Health Sciences, Winston-Salem
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
RecruitingObservational study
- Wake Forest University Health Sciences, Winston-Salem
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Winston-Salem
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Wake Forest University Health Sciences, Winston-Salem
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RecruitingPhase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
Recruiting
- Wake Forest University Health Sciences, Winston-Salem
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
RecruitingPhase 2
- Wake Forest University Health Sciences, Winston-Salem
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
- Lung Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.